IL2 and type 1 diabetes mellitus: To date, clinical research with radiolabelled IL-2 (e.g. 99mTc-HYNIC-IL-2 [7]) has been performed in various inflammatory diseases in over 1000 patients (inflammatory bowel disease, atherosclerosis, thyroiditis, diabetes type 1, etc.)[6, 8, 9].